SSc dermal fibroblasts (SScDFs) have higher expression/activity of NADPH oxidase and produce higher levels of ROS compared with normal human dermal fibroblasts (NHDFs), which is further enhanced by profibrotic TGF-β (4, 5). The gene discussed is TGFB1; the disease is systemic sclerosis.